MetaVia Inc. MetaVia Inc.

MetaVia Inc.

MTVA

주식 순위 #32894
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
주가
$1.28
마지막 동기화: 2026-10-20
시가총액
$8.43M
변동 (1일)
4.07%
변동 (1년)
-21.47%
국가
US
거래 MetaVia Inc. (MTVA)

카테고리

Healthcare
MetaVia Inc. (MTVA)의 주식 분할 이력
MetaVia Inc. 주식 (심볼: MTVA)은 총 3회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Dec 21, 2023에 발생했습니다.
Dec 31, 2019 이전에 매수한 MTVA 주식 1주는 현재 0.00016666666666667주의 MTVA 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2023-12-21 1:8 x0.125 x0.00016666666666667
2022-09-13 1:30 x0.033333333333333 x0.0013333333333333
2019-12-31 1:25 x0.04 x0.04
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL